| Dr Alexander Jon Butts, DPT | |
|
3200 E Racine St, Janesville, WI 53546-2343 | |
| (608) 373-8000 | |
| (608) 371-8935 |
| Full Name | Dr Alexander Jon Butts |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 3200 E Racine St, Janesville, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073006284 | NPI | - | NPPES |
| 1073006284 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 14223-24 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Health Systems Inc | 7012827983 | 1068 |
News Archive
POF is not only associated with infertility but also with significantly increased morbidity and mortality, as well as a decreased quality of life equivalent to that of people with type 2 diabetes or rheumatoid arthritis, said Dr. Rumana Islam, from Imperial College, London, UK.
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.
Small studies have suggested that a group of medications called RAS inhibitors may be harmful in persons with advanced chronic kidney disease, and physicians therefore often stop the treatment in such patients.
A team of radiation oncologists at the Zucker School of Medicine at Hofstra/Northwell in the United States aimed to determine if COVID-19 infected cancer patients receiving radiation therapy (RT) have any different outcome than non-infected patients.
› Verified 1 days ago
| Provider Name | Dean Health Systems Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053358846 PECOS PAC ID: 7012827983 Enrollment ID: O20031105000584 |
News Archive
POF is not only associated with infertility but also with significantly increased morbidity and mortality, as well as a decreased quality of life equivalent to that of people with type 2 diabetes or rheumatoid arthritis, said Dr. Rumana Islam, from Imperial College, London, UK.
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.
Small studies have suggested that a group of medications called RAS inhibitors may be harmful in persons with advanced chronic kidney disease, and physicians therefore often stop the treatment in such patients.
A team of radiation oncologists at the Zucker School of Medicine at Hofstra/Northwell in the United States aimed to determine if COVID-19 infected cancer patients receiving radiation therapy (RT) have any different outcome than non-infected patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander Jon Butts, DPT 3401 Maple Grove Dr, Madison, WI 53719-5013 Ph: () - | Dr Alexander Jon Butts, DPT 3200 E Racine St, Janesville, WI 53546-2343 Ph: (608) 373-8000 |
News Archive
POF is not only associated with infertility but also with significantly increased morbidity and mortality, as well as a decreased quality of life equivalent to that of people with type 2 diabetes or rheumatoid arthritis, said Dr. Rumana Islam, from Imperial College, London, UK.
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.
Small studies have suggested that a group of medications called RAS inhibitors may be harmful in persons with advanced chronic kidney disease, and physicians therefore often stop the treatment in such patients.
A team of radiation oncologists at the Zucker School of Medicine at Hofstra/Northwell in the United States aimed to determine if COVID-19 infected cancer patients receiving radiation therapy (RT) have any different outcome than non-infected patients.
› Verified 1 days ago
Alesia L Drake, DPT, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6842 Fax: 608-741-6953 | |
Macy G Bolt, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8935 | |
Ann Slinde, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2050 Morse Street Suite 150, Janesville, WI 53545 Phone: 608-305-1028 Fax: 608-554-4787 | |
Joshua T Lehr, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 Fax: 608-756-7225 | |
Kelsey E Olson, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-373-8790 Fax: 608-371-8935 | |
Marcus A Sojka, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3200 E Racine St, Janesville, WI 53546 Phone: 608-371-8000 Fax: 608-371-8935 | |
Peter W. Menges, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 557 N Washington St, Janesville, WI 53548 Phone: 608-754-6000 Fax: 608-755-7892 |